A total of 66 Latvian innovation projects were carried out during the first phase of the Biomedical and Photonics Innovation Platform “BioPhoT”. The platform has played a significant role in accelerating scientific developments towards commercialisation, with the average innovation readiness level of projects increasing by 4.6 points at the mid-term evaluation.
Project teams have showcased their technologies at international events, initiated collaborations with companies and signed licensing agreements, paving the way for the creation of new businesses. At the same time, collaboration between research and industry has been strengthened, with 41 industry challenges identified and connections established with approximately 400 partners.
On 29 October, the second annual “BioPhoT” conference took place, bringing together more than 300 researchers, entrepreneurs, innovators and other industry representatives. The conference featured presentations of the results achieved by projects supported by the platform, as well as opportunities for their further development, including nearly 40 innovation prototypes.
Considerable attention was also devoted to the next stages of project development. To date, the innovation readiness levels of projects supported by the platform have increased by an average of 4.6 points at the mid-term assessment stage. On average, progress has been recorded in three of the six innovation readiness components. The readiness levels for intellectual property and securing additional funding have each improved by an average of one point. These results demonstrate the potential of the ideas to progress further towards development and commercialisation.
A recording of the conference is available on the “BioPhoT” platform’s YouTube channel.
“One of the most significant benefits of ‘BioPhoT’ is the closer collaboration and shared understanding it fosters between academia and industry on how to transform scientific ideas into solutions that meet the needs of businesses and society. During the first phase of its operation, we implemented 66 innovation projects out of 221 applications received. We have seen that, with targeted support, project teams can not only develop technological solutions in a relatively short period of time, but also identify potential users and partners for collaboration. This is an important step in the journey from a promising scientific development to a market-ready product or technology,” says Osvalds Pugovičs, Head of ‘BioPhoT’.
From scientific ideas to technology prototypes
The platform has supported innovative research ideas from both its partner institutions and other higher education and research institutions, including Daugavpils University, Latvia University of Life Sciences and Technologies, and Ventspils University of Applied Sciences. The portfolio of projects is broad and interdisciplinary, covering biotechnology and drug development, medical technologies and biomaterials, diagnostics, monitoring and digital health, photonics and optical sensing, environmental and energy solutions, as well as advanced materials and industrial technologies.
To strategically support the further development of these projects, “BioPhoT”, in collaboration with the consultancy company “Civitta”, has carried out an assessment of all 66 projects. Based on the maturity of the results achieved and their potential for further development, 27 teams have been selected and are currently being matched with the most suitable collaboration partners. This process draws on a methodology developed by “Civitta”, which enables collaboration opportunities to be tailored to the specific needs of each team.
Latvian innovation attracts interest from international industry and investors
One of the key areas of the platform’s work is facilitating connections with potential investors and collaboration partners in international markets. A major milestone was the platform’s participation in, and representation of its projects at, the “Hello Tomorrow Global Summit 2026”, one of the world’s leading events dedicated to deep-tech innovation.
Representatives of the ten most advanced “BioPhoT” project teams presented their developments to more than 300 venture capital investors during the event’s Investor Day.
At the same time, the platform works to identify the needs of Latvian and international industries and connect them with research capabilities. A total of 41 industry challenges have been identified in cooperation with representatives of the business sectors in Latvia and abroad. This process has drawn on the network of the Investment and Development Agency of Latvia’s (LIAA) foreign representative offices, as well as photonics and life sciences clusters in France and Germany. Targeted cooperation has been established with 25 industry associations and chambers of commerce, including the Foreign Investors Council in Latvia, the German-Baltic Chamber of Commerce (Auslandshandelskammer), the Latvian Chamber of Commerce and Industry, the Latvian Chemical and Pharmaceutical Entrepreneurs Association, Greentech Latvia and Cleantech Latvia.
International partnerships are already delivering tangible results. The German photonics industry organisations “SPECTARIS” and “OpTecBB” are promoting “BioPhoT” projects and industry challenges among their members, while “OpTecBB” has selected seven priority projects and three additional projects for further promotion within the German industry.
Overall, “BioPhoT” has established contacts with approximately 400 external partners, more than 200 of whom are new contacts. Active dialogue has been initiated with over 70 partners, and more than 150 partnership-building meetings have taken place. Concrete collaboration has been initiated in four industry challenge areas without financial support from “BioPhoT” for the projects concerned. Meanwhile, two project teams supported by the platform have signed technology licensing agreements with industry partners. A further three teams, having identified suitable and interested industry partners, have submitted applications to European Commission calls designed to support the further commercialisation of their developments.
Targeted support to help researchers commercialise their technologies
To help researchers better understand industry needs and prepare their technologies for commercialisation, “BioPhoT” has implemented a dedicated training programme. It includes personalised commercialisation coaching for project teams, in-depth training on the principles of commercialisation and the fundamentals of technology transfer, as well as guidance on regulatory requirements and opportunities for securing additional funding. This approach enables researchers to assess the practical applications, market potential and future growth opportunities of their innovations at an early stage of development.
The experience gained during the first phase of operation will make it possible to tailor support even more closely to project needs in the next phase of development. This will involve refining project selection and results assessment approaches and introducing incubation programmes tailored to each team. Particular emphasis will be placed on building industry partnerships, securing further funding and investment, and exploring opportunities for technology commercialisation.
“Innovation takes time. Depending on the technology and market conditions, it can take several years for an idea to achieve commercial success. Therefore, the role of ‘BioPhoT’ is not only to provide initial funding, but also to help teams as effectively as possible to prepare for the next stages of development, find suitable industry partners and secure the investment they need,” emphasises Osvalds Pugovičs.
“BioPhoT” is a long-term initiative aimed at ensuring continuity in research, helping promising projects progress to the next stages of development, strengthening existing companies and fostering the creation of new businesses, including spin-off companies originating from research institutions. The platform is planned to operate over an eight-year period, with funding expected to be available from 2027 to 2032, depending on the results achieved.
The Biomedical and Photonics Research Platform for the Development of Innovative Products (“BioPhoT”) is implemented under the leadership of the National Research and Innovation Institute by the Institute of Electronics and Computer Science, the University of Latvia, the Institute of Solid State Physics of the University of Latvia, the Latvian State Institute of Wood Chemistry, the Institute of Food Safety, Animal Health and Environment “BIOR”, Rīga Stradiņš University and Riga Technical University.
Project No. IVPP-EM-Inovācija-2024/1-0002, “Biomedical and Photonics Research Platform for the Development of Innovative Products (BioPhoT)”, is implemented under the national research programme “Innovation Fund – Long-Term Research Programme”, funded by the Ministry of Economics of the Republic of Latvia.
Source
Renāte Franke “BioPhoT”






